Methylation of AKAP12α promoter in lung cancer

Anticancer Research

Volumn 30, Issue 11, 2010, Pages 4595-4600

  Jo, Uk Hyun ^a,b   Whang, Young Mi ^a,b   Sung, Jae Sook ^a,b   Kim, Yeul Hong ^a,b  

^a Korea University College of Medicine   (South Korea)

^b College of Medicine   (South Korea)

Author keywords

AKAP12 ; Lung neoplasms; NSCLC; Promoter methylation

Indexed keywords

A KINASE ANCHORING PROTEIN 12ALPHA; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; DNA METHYLATION; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION;

A KINASE ANCHOR PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; TUMOR CELLS, CULTURED;

EID: 78650232331     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Streb JW, Kitchen CM, Gelman IH and Miano JM: Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles. J Biol Chem 279: 56014-56023, 2004.
2. Malbon CC, Tao J, Shumay E and Wang HY: AKAP (A-kinase anchoring protein) domains: beads of structure-function on the necklace of G-protein signalling. Biochem Soc Trans 32: 861-864, 2004.
3. Yoon DK, Jeong CH, Jun HO, Chun KH, Cha JH, Seo JH, Lee HY, Choi YK, Ahn BJ, Lee SK and Kim KW: AKAP12 induces apoptotic cell death in human fibrosarcoma cells by regulating CDKI-cyclin D1 and caspase-3 activity. Cancer Lett 254: 111-118, 2007.
4. Choi MC, Jong HS, Kim TY, Song SH, Lee DS, Lee JW, Kim NK and Bang YJ: AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 23: 7095-7103, 2004.
5. Flotho C, Paulun A, Batz C and Niemeyer CM: AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies. Br J Haematol 138: 644-650, 2007. (Pubitemid 47206724)
6. Zochbauer-Muller S, Minna JD and Gazdar AF: Aberrant DNA methylation in lung cancer: biological and clinical implications. Oncologist 7: 451-457, 2002. (Pubitemid 35266138)
7. Ushijima T: Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5: 223-231, 2005. (Pubitemid 40314953)
8. Johnson PJ and Lo YM: Plasma nucleic acids in the diagnosis and management of malignant disease. Clin Chem 48: 1186-1193, 2002.
9. Anker P, Mulcahy H, Chen XQ and Stroun M: Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 18: 65-73, 1999. (Pubitemid 29411092)
10. Taback B and Hoon DS: Circulating nucleic acids and proteomics of plasma/serum: clinical utility. Ann NY Acad Sci 1022: 1-8, 2004. (Pubitemid 38951574)
11. Marsit CJ, Kim DH, Liu M, Hinds PW, Wiencke JK, Nelson HH and Kelsey KT: Hypermethylation of RASSFlA and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence. Int J Cancer 114: 219-223, 2005.
12. Tai KY, Shiah SG, Shieh YS, Kao YR, Chi CY, Huang E, Lee HS, Chang LC, Yang PC and Wu CW: DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression. Oncogene 26: 3989-3997, 2007.
13. Jo UH, Whang YM, Kim HK and Kim YH: AKAP12α is associated with promoter methylation in lung cancer. Cancer Res Treat 38: 144-151, 2007.
14. Usadel H, Brabender J, Danenberg KD, Jeronimo C, Harden S, Engles J, Danenberg PV, Yang S and Sidransky D: Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 62: 371-375, 2002.
15. Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, Bocklage TJ, Johnson DH and Schiller JH: Predicting gene promoter methylation in non-small cell lung cancer by evaluating sputum and serum. Br J Cancer 96: 1278-1283, 2007.
16. Li QL, Kim HR, Kim WJ, Choi JK, Lee YH, Kim HM, Li LS, Kim H, Chang J, Ito Y, Youl Lee K and Bae SC: Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun 314: 223-228, 2004.
17. Jin Z, Hamilton JP, Yang J, Mori Y, Olaru A, Sato F, Ito T, Kan T, Cheng Y, Paun B, David S, Beer DG, Agarwal R, Abraham JM and Meltzer SJ: Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression. Cancer Epidemiol Biomarkers Prev 17: 111-117, 2008.
18. Tao J and Malbon CC: G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential signaling to MAPK and GPCR recycling. J Mol Signal 3: 19, 2008.
19. Choi MC, Lee YU, Kim SH, Lee JH, Park JH, Streb JW, Oh DY, Im SA, Kim TY, Jong HS and Bang YJ: Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells. Int J Biochem Cell Biol 40: 2534-2543, 2008.
20. Lin X, Tombler E, Nelson PJ, Ross M and Gelman IH: A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem 271: 28430-28438, 1996. (Pubitemid 26374662)
21. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB and Herman JG: Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59: 67-70, 1999. (Pubitemid 29062958)
22. Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K, Kozuki T, Aoe M, Kiura K, Ueoka H and Tanimoto M: Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res 11: 1219-1225, 2005. (Pubitemid 40175774)